Global Retirement Partners’s Alder Biopharmaceuticals ALDR Stock Holding History

Global Retirement Partners’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-45	Closed	-$1K	–	1756
2019 Q3	$1K	Hold	45	–	–	﹤0.01%	1583
2019 Q2	$1K	Hold	45	–	–	﹤0.01%	1577
2019 Q1	$1K	Hold	45	–	–	﹤0.01%	1503
2018 Q4	$0	Hold	45	–	–	﹤0.01%	1605
2018 Q3	$1K	Hold	45	–	–	﹤0.01%	1516
2018 Q2	$1K	Hold	45	–	–	﹤0.01%	1508
2018 Q1	$1K	Hold	45	–	–	﹤0.01%	1463
2017 Q4	$1K	Hold	45	–	–	﹤0.01%	1414
2017 Q3	$1K	Hold	45	–	–	﹤0.01%	1199
2017 Q2	$1K	Hold	45	–	–	﹤0.01%	1123
2017 Q1	$1K	Hold	45	–	–	﹤0.01%	1081
2016 Q4	$1K	Buy	+45	New	+$1.17K	﹤0.01%	1024

Global Retirement Partners's ALDR Position: Q4 2019 in Review

Global Retirement Partners sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 45 shares — an estimated $1K sold.

Global Retirement Partners first reported a position in ALDR in Q4 2016 and held it in 12 quarters. The position peaked at $1K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Global Retirement Partners reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Global Retirement Partners sold 45 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1K.
Global Retirement Partners first reported a position in Alder Biopharmaceuticals in Q4 2016 and held it in 12 quarters.
Global Retirement Partners's Alder Biopharmaceuticals position peaked at $1K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Global Retirement Partners's 13F filing for Q4 2019, filed 23 Jan 2020.